Measuring the quality and safety of upper endoscopy in patients taking glucagon-like peptide 1 receptor agonists

Measuring the quality and safety of upper endoscopy in patients taking glucagon-like peptide 1 receptor agonists

Bibliographic Details
Main Authors:	Bansal, R, Khan, RJ, Grover, SC
Format:	Journal article
Language:	English
Published:	Elsevier 2024

Similar Items

Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes
by: Seungah Lee, et al.
Published: (2017-03-01)

Glucagon‐like peptide‐1 receptor agonists and kidney outcomes
by: Richard J. MacIsaac, et al.
Published: (2024-10-01)

Nephroprotective potential of glucagon-like peptide-1 receptor agonists
by: Minara S. Shamkhalova, et al.
Published: (2020-04-01)

Glucagon-like peptide-1 receptor agonists in neoplastic diseases
by: Lisan Ji, et al.
Published: (2024-09-01)

Cardiovascular Effects of Glucagon-Like Peptide-1 Receptor Agonists
by: Yu Mi Kang, et al.
Published: (2016-06-01)

Glucagon-like peptide-1 receptor agonists: Prospects for use in rheumatology
by: Е. L. Nasonov, et al.
Published: (2024-04-01)

Glucagon-like peptide-1 receptor agonists in patients treated with antipsychotics
by: A. Delgado, et al.
Published: (2021-04-01)

The potential of glucagon-like peptide-1 receptor agonists in heart failure
by: Frederik Flindt Kreiner, et al.
Published: (2022-09-01)

Effect of glucagon-like peptide-1 receptor agonists in patients with psoriasis
by: Marwa R. Al-Badri, et al.
Published: (2014-04-01)

Glucagon-like peptide-1 receptor agonists: a systematic review of comparative effectiveness research
by: Levin PA, et al.
Published: (2017-04-01)

A Review and Meta-Analysis of the Safety and Efficacy of Using Glucagon-like Peptide-1 Receptor Agonists
by: En-Hao Hu, et al.
Published: (2024-02-01)

Glucagon-Like Peptide-1 Receptor Agonist Liraglutide Ameliorates the Development of Periodontitis
by: Noritaka Sawada, et al.
Published: (2020-01-01)

Glucagon-like peptide-1 receptor agonists and derivatives in the treatment of obesity - review
by: Michal Rabenda, et al.
Published: (2024-08-01)

Glucagon-like peptide-1 receptor agonists for the management of diabetic peripheral neuropathy
by: Chunyan Liu, et al.
Published: (2024-01-01)

Pharmacoeconomic characteristics of agonists of receptors for glucagon-like peptide-1 and medicines on their base
by: I. N. Dyakov, et al.
Published: (2021-08-01)

Glucagon-like peptide 1 receptor agonists and thyroid cancer: is it the time to be concerned?
by: Giuseppe Lisco, et al.
Published: (2023-10-01)

A novel, long-acting glucagon-like peptide receptor-agonist: dulaglutide
by: Gurung T, et al.
Published: (2015-08-01)

Glucagon‐like peptide agonists: A prospective review
by: Zamara Mariam, et al.
Published: (2024-01-01)

Organoprotective effects of glucagon-like peptide-1 receptor agonists with regard to findings of evidencebased cardiovascular safety studies
by: Yu. Sh. Khalimov, et al.
Published: (2020-01-01)

Use of glucagon-like peptide type 1 receptor agonists in kidney transplant recipients
by: Luis Alberto Vigara, et al.
Published: (2024-11-01)

Glucagon‐Like Peptide‐1 Receptor Agonists and Anesthesia—Are We Clearer on the Correct Approach?
by: Zachary Bloomgarden
Published: (2024-12-01)

Role of glucagon-like peptide-1 receptor agonists in Alzheimer’s disease and Parkinson’s disease
by: Chien-Tai Hong, et al.
Published: (2024-11-01)

Glucagon-like peptide 1 receptor agonists in obesity treatment - a literature review
by: Aleksander Jentkiewicz, et al.
Published: (2025-02-01)

Evolution of glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes
by: Gagik R. Galstyan, et al.
Published: (2017-10-01)

Glucagon-like Peptide-1 Receptor Agonists Reduce Surgical Complications in Diabetic Patients
by: Ashley Zhang, BSE, et al.
Published: (2024-09-01)

Impact of Glucagon-like Peptide-1 Receptor Agonists on Intestinal Epithelial Cell Barrier
by: Takizawa Y., et al.
Published: (2024-08-01)

The Effect of Glucagon-Like Peptide-2 Receptor Agonists on Colonic Anastomotic Wound Healing
by: Heather A. Redstone, et al.
Published: (2010-01-01)

The Therapeutic Potential of Glucagon-like Peptide 1 Receptor Agonists in Traumatic Brain Injury
by: Anja Harej Hrkać, et al.
Published: (2024-10-01)

Research Progress on the Cardiovascular Protective Effect of Glucagon-Like Peptide-1 Receptor Agonists
by: Rui Song, et al.
Published: (2022-01-01)

Amelioration of muscle wasting by glucagon‐like peptide‐1 receptor agonist in muscle atrophy
by: Yeonhee Hong, et al.
Published: (2019-08-01)

Dual Glucose-Dependent Insulinotropic Polypeptide and Glucagon-Like Peptide-1 Receptor Agonists
by: Dilek Tüzün
Published: (2022-06-01)

The Role of Glucagon-Like Peptide-1 Receptor Agonists in Chronic Obstructive Pulmonary Disease
by: Wang W, et al.
Published: (2023-02-01)

Association of glucagon‐like peptide‐1 receptor agonist treatment with gastric residue in an esophagogastroduodenoscopy
by: Toshiko Kobori, et al.
Published: (2023-06-01)

Should glucagon‐like peptide‐1 receptor agonist treatment be withheld in preoperative management?
by: Zachary Bloomgarden
Published: (2023-09-01)

Patient preferences for glucagon-like peptide-1 receptor–agonist treatment attributes
by: Thieu VT, et al.
Published: (2019-04-01)

Experiences with Glucagon-Like Peptide-1 Receptor Agonist in Children with Acquired Hypothalamic Obesity
by: Jiska van Schaik, et al.
Published: (2020-08-01)

Effect of Glucagon-like peptide-1 receptor agonists on dyslipidemia in type 2 diabetes
by: Elizabeth A. Cristiano, et al.
Published: (2020-09-01)

The Road towards Triple Agonists: Glucagon-Like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide and Glucagon Receptor - An Update
by: Agnieszka Jakubowska, et al.
Published: (2024-02-01)

Insulin–glucagon‐like peptide‐1 receptor agonist relay and glucagon‐like peptide‐1 receptor agonist first regimens in individuals with type 2 diabetes: A randomized, open‐label trial study
by: Yumie Takeshita, et al.
Published: (2022-06-01)

An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental health disorders
by: De Giorgi, R, et al.
Published: (2025)